
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
26.4
38.06
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd hold over its rivals?
What risks and challenges
does Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide an overview of the primary business activities
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
What unique competitive advantages
does Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd hold over its rivals?
What risks and challenges
does Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide P/S
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide P/E
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide P/OCF
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide P/FCFE
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide P/B
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide EV/S
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide EV/GP
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide EV/EBITDA
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide EV/EBIT
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide EV/OCF
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide EV/FCFF
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide EV/IC
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Show me price targets
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd made by professional analysts.
What are the Revenue projections
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
How accurate were the past Revenue estimates
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
What are the Net Income projections
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
How accurate were the past Net Income estimates
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
What are the EPS projections
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
How accurate were the past EPS estimates
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
What are the EBIT projections
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
How accurate were the past EBIT estimates
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Compare the revenue forecasts
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd compared to its peers.
Compare the P/E ratios
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd with its peers.
Analyze the financial leverage
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd compared to its main competitors.
Show all profitability ratios
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide ROE
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide ROA
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide ROIC
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide ROCE
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide Gross Margin
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide Operating Margin
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide Net Margin
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide FCF Margin
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Show all solvency ratios
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide D/E Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide D/A Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide Interest Coverage Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide Altman Z-Score Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide Quick Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide Current Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
Provide Cash Ratio
for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
What is the historical Revenue growth
over the last 5 years for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
What is the historical Net Income growth
over the last 5 years for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
What is the current Free Cash Flow
of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd.
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
CN |
![]() |
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
25.5B CNY | 15.8 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
687.3B USD | 77.1 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 6 930.6 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
368.7B USD | 15.3 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK | 16 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
206.7B CHF | 11 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
182.3B CHF | 12.4 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
161.1B GBP | 199.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
195.2B USD | 10.5 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 632.4 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
134.2B USD | 12.5 |
|
CN |
![]() |
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
Average EV/OCF:
721.2
15.8
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
77.1
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
6 930.6
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
15.3
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
16
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
11
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
12.4
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
199.1
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
10.5
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
632.4
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
12.5
|
|
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.